Feb 29, 2024
Press communication Lund, Sweden, February 29 This is a translation of the Swedish press release published 2024-02-29, 07.00 CET Neola Medical AB (publ) will commence a Human Factors Validation Study in March 2024 with Neola®, the company’s medical device for...
Feb 26, 2024
Neola Medical’s product for lung monitoring of preterm born infants, Neola®, is one of ten innovations selected to be presented to a panel of judges at the Stanford Pediatric Device Consortium (PDC) Accelerator Pitch, to be held alongside the Michael R Harrison...
Feb 15, 2024
CEO Hanna Sjöström comments on Neola Medical’s Q4 report of 2023 in BioStock’s studio. Following the interview, Jonas Söderström, CEO of BioStock, comments on Neola Medical’s development since its listing on the stock exchange. Se the interview...
Feb 15, 2024
Apart from presenting the company’s financial position and the important highlights from this quarter, they also talk more about the significance of this year’s achieved milestones, the commercialization plan for market launch, and the focus for 2024. After the...
Feb 14, 2024
Press communication Lund, Sweden, February 14 This is a translation of the Swedish press release published 2024-02-14, 08.00 CET Neola Medical AB (publ) today publishes the Q4 report of 2023 (in Swedish). The report is available at the company’s website and is...
Feb 8, 2024
Today, on February 8, it’s time for MedInnovation 2024 at Medicon Village in Lund. Neola Medical’s CEO Hanna Sjöström will be present and present as a guest speaker on how life science companies like Neola Medical strengthen Skåne as an innovation arena...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
